CXCR4 mutations in lymphoplasmacytic lymphoma lead to altered CXCR4 expression
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - November 8, 2018 Category: Hematology Authors: Laura S. Hiemcke ‐Jiwa,
Roos J. Leguit,
N. Mehdi Jiwa,
Manon M. H. Huibers,
Monique C. Minnema Tags: Correspondence Source Type: research
A phase II trial of eltrombopag for patients with chronic lymphocytic leukaemia (CLL) and thrombocytopenia
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - November 8, 2018 Category: Hematology Authors: Shilpa Paul,
Nitin Jain,
Alessandra Ferrajoli,
Susan O'Brien,
Jan Burger,
Michael Keating,
William Wierda Tags: Correspondence Source Type: research
Phase I/II study on cytarabine and idarubicin combined with escalating doses of clofarabine in newly diagnosed patients with acute myeloid leukaemia and high risk for induction failure (AMLSG 17 ‐10 CIARA trial)
British Journal of Haematology,Volume 183, Issue 2, Page 235-241, October 2018. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 31, 2018 Category: Hematology Authors: J ürgen Krauter,
Walter Fiedler,
Richard F. Schlenk,
Peter Paschka,
Felicitas Thol,
Michael Lübbert,
Mohammed Wattad,
Mareike Verbeek,
Christian Könecke,
Barbara Neuhaus,
Armin Papkalla,
Maxim Kebenko,
Melanie Janning,
Konstanze Döhner,
Source Type: research
von Willebrand factor clearance – biological mechanisms and clinical significance
British Journal of Haematology,Volume 183, Issue 2, Page 185-195, October 2018. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 31, 2018 Category: Hematology Authors: Jamie M. O'Sullivan,
Soracha Ward,
Michelle Lavin,
James S. O'Donnell Source Type: research
Issue Information
British Journal of Haematology,Volume 183, Issue 2, Page 157-164, October 2018. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 31, 2018 Category: Hematology Source Type: research
Comment on: Type 1 cryoglobulinaemia leading to gangrene of the toes and ischaemic ulceration
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 30, 2018 Category: Hematology Authors: Utku Iltar Source Type: research
Advances in POEMS treatment and the need to define standardised outcome measures
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 30, 2018 Category: Hematology Authors: Stephen Keddie,
Shirley D'Sa,
Michael P. Lunn Source Type: research
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 23, 2018 Category: Hematology Authors: Michela Faleschini,
Federica Melazzini,
Caterina Marconi,
Tania Giangregorio,
Tommaso Pippucci,
Elena Cigalini,
Alessandro Pecci,
Roberta Bottega,
Ugo Ramenghi,
Timo Siitonen,
Marco Seri,
Annalisa Pastore,
Anna Savoia,
Patrizia Noris Source Type: research
Avatrombopag
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 23, 2018 Category: Hematology Authors: James B. Bussel Source Type: research
Primary cutaneous acral CD8+ T ‐cell lymphomas relapse more frequently in younger patients
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 23, 2018 Category: Hematology Authors: Eve Maubec,
Eduardo Marinho,
Liliane Laroche,
Andrew Mitchell,
Florent Grange,
Tony Petrella Source Type: research
Sickle related events following cardiac catheterisation: risk implication for other invasive procedures
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 23, 2018 Category: Hematology Authors: Rosario Di Maggio,
Anna Conrey,
Tiffani N. Taylor,
Robert J. Lederman,
Toby Rogers,
Jim Nichols,
Shenikqua Bouges,
Caterina P. Minniti,
Gregory J. Kato,
Arun S. Shet,
Matthew M. Hsieh Source Type: research
Issue Information
British Journal of Haematology,Volume 183, Issue 1, Page 1-10, October 2018. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 19, 2018 Category: Hematology Source Type: research
Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 19, 2018 Category: Hematology Authors: Lauren Campbell,
Fotios Panitsas,
Supratik Basu,
Francis Anyanwu,
Sophie Lee,
Berne Ferry,
Karthik Ramasamy Source Type: research
Unravelling the suboptimal response of TP53 ‐mutated chronic lymphocytic leukaemia to ibrutinib
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 19, 2018 Category: Hematology Authors: Anna Guarini,
Nadia Peragine,
Monica Messina,
Marilisa Marinelli,
Caterina Ilari,
Luciana Cafforio,
Sara Raponi,
Silvia Bonina,
Paola Mariglia,
Francesca R. Mauro,
Gianluca Gaidano,
Ilaria Del Giudice,
Robin Fo à Source Type: research
Early molecular response ≤1% has strong prognostic impact for CML patients that switch to second‐line therapy with BCR‐ABL1 ≤10% and no major molecular response
British Journal of Haematology, EarlyView. (Source: British Journal of Haematology)
Source: British Journal of Haematology - October 19, 2018 Category: Hematology Authors: Simone Bonecker,
Gabriela Carvalho,
Jane Dobbin,
Ilana Zalcberg,
Rony Schaffel Source Type: research
